NAS:GH (USA)

Guardant Health Inc

$ 75.81 4.31 (6.03%)
Volume: 4,683,694 Avg Vol (1m): 1,351,275
Market Cap $: 6.60 Bil Enterprise Value $: 6.14 Bil
P/E (TTM): 0.00 P/B: 13.92
Earnings Power Value 0
Net Current Asset Value 4.67
Tangible Book 5.36
Projected FCF 0
Median P/S Value 65.56
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 8/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 2381.93
Cash-To-Debt ranked lower than
100.00% of 261 companies
in the Diagnostics & Research industry.
Industry Max: 32990, Med: 3.52, Min: 0.01
GH: 2381.93
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 5.59, Med: 1074.26, Max: 2381.93
Current: 2381.93
5.59
2381.93
Equity-to-Asset 0.81
Equity-to-Asset ranked lower than
100.00% of 239 companies
in the Diagnostics & Research industry.
Industry Max: 0.97, Med: 0.61, Min: -2.81
GH: 0.81
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.74, Med: 0.81, Max: 0.9
Current: 0.81
0.74
0.9
Altman Z-Score 36.75
DISTRESS
GREY
SAFE

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -88.57
Operating Margin ranked lower than
100.00% of 242 companies
in the Diagnostics & Research industry.
Industry Max: 53.36, Med: -0.59, Min: -70300
GH: -88.57
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -173.66, Med: -153.71, Max: -88.57
Current: -88.57
-173.66
-88.57
Net Margin % -82.97
Net Margin ranked lower than
100.00% of 241 companies
in the Diagnostics & Research industry.
Industry Max: 41.13, Med: -2.48, Min: -119600
GH: -82.97
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -182.74, Med: -166.97, Max: -82.97
Current: -82.97
-182.74
-82.97
ROE % -32.79
ROE ranked lower than
100.00% of 242 companies
in the Diagnostics & Research industry.
Industry Max: 61.7, Med: -6.75, Min: -12038.19
GH: -32.79
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -57.89, Med: -45.84, Max: -21.49
Current: -32.79
-57.89
-21.49
ROA % -24.48
ROA ranked lower than
100.00% of 262 companies
in the Diagnostics & Research industry.
Industry Max: 1174.65, Med: -4.54, Min: -1248.4
GH: -24.48
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -39.58, Med: -36.22, Max: -18.11
Current: -24.48
-39.58
-18.11
ROC (Joel Greenblatt) % -363.90
ROC (Joel Greenblatt) ranked lower than
100.00% of 259 companies
in the Diagnostics & Research industry.
Industry Max: 17601.65, Med: -9.57, Min: -3842027.78
GH: -363.9
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -521.84, Med: -341.26, Max: -316.64
Current: -363.9
-521.84
-316.64

» GH's 30-Y Financials

Financials (Next Earnings Date: 2019-08-09 Est.)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:GH

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Diagnostics & Research    NAICS : 621511    SIC : 8071
Compare
Traded in other countries
Address 505 Penobscot Drive, Redwood City, CA, USA, 94063

Ratios

Current vs industry vs history
PB Ratio 13.92
PB Ratio ranked lower than
100.00% of 245 companies
in the Diagnostics & Research industry.
Industry Max: 270, Med: 4.02, Min: 0.15
GH: 13.92
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 6.1, Med: 11.55, Max: 17.98
Current: 13.92
6.1
17.98
PS Ratio 58.25
PS Ratio ranked lower than
100.00% of 230 companies
in the Diagnostics & Research industry.
Industry Max: 6350, Med: 3.81, Min: 0.07
GH: 58.25
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 31.95, Med: 50.35, Max: 75.25
Current: 58.25
31.95
75.25
EV-to-EBIT -67.84
EV-to-EBIT ranked lower than
100.00% of 118 companies
in the Diagnostics & Research industry.
Industry Max: 341.21, Med: 25.06, Min: 5.74
GH: -67.84
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -87.9, Med: -54.6, Max: -30.5
Current: -67.84
-87.9
-30.5
EV-to-EBITDA -74.50
EV-to-EBITDA ranked lower than
100.00% of 132 companies
in the Diagnostics & Research industry.
Industry Max: 486.47, Med: 20.75, Min: 3.94
GH: -74.5
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -96.5, Med: -60, Max: -33.4
Current: -74.5
-96.5
-33.4
EV-to-Revenue 55.51
EV-to-Revenue ranked lower than
100.00% of 242 companies
in the Diagnostics & Research industry.
Industry Max: 19679, Med: 4.24, Min: 0.09
GH: 55.51
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 27.9, Med: 46.6, Max: 71.9
Current: 55.51
27.9
71.9
Current Ratio 10.63
Current Ratio ranked lower than
100.00% of 250 companies
in the Diagnostics & Research industry.
Industry Max: 97.84, Med: 2.58, Min: 0.02
GH: 10.63
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 7.22, Med: 9.76, Max: 12.38
Current: 10.63
7.22
12.38
Quick Ratio 10.42
Quick Ratio ranked lower than
100.00% of 250 companies
in the Diagnostics & Research industry.
Industry Max: 97.84, Med: 2.14, Min: 0.02
GH: 10.42
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 7.03, Med: 9.55, Max: 12.01
Current: 10.42
7.03
12.01
Days Inventory 51.02
Days Inventory ranked lower than
100.00% of 204 companies
in the Diagnostics & Research industry.
Industry Max: 917.88, Med: 79.76, Min: 0.37
GH: 51.02
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 45.68, Med: 58.04, Max: 69.36
Current: 51.02
45.68
69.36
Days Sales Outstanding 95.67
Days Sales Outstanding ranked lower than
100.00% of 204 companies
in the Diagnostics & Research industry.
Industry Max: 521.64, Med: 67.51, Min: 1
GH: 95.67
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 50.52, Med: 93.64, Max: 143.72
Current: 95.67
50.52
143.72
Days Payable 55.05
Days Payable ranked lower than
100.00% of 187 companies
in the Diagnostics & Research industry.
Industry Max: 981.81, Med: 63.34, Min: 1
GH: 55.05
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 52.08, Med: 57.7, Max: 89.89
Current: 55.05
52.08
89.89

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 14.14
Price-to-Tangible-Book ranked lower than
100.00% of 207 companies
in the Diagnostics & Research industry.
Industry Max: 272.36, Med: 6.46, Min: 0.21
GH: 14.14
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 6.79, Med: 10.55, Max: 14.6
Current: 14.14
6.79
14.6
Price-to-Median-PS-Value 1.16
Price-to-Median-PS-Value ranked lower than
100.00% of 193 companies
in the Diagnostics & Research industry.
Industry Max: 7.22, Med: 1.01, Min: 0.01
GH: 1.16
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.71, Med: 0.95, Max: 1.21
Current: 1.16
0.71
1.21
Earnings Yield (Joel Greenblatt) % -1.45
Earnings Yield (Greenblatt) ranked lower than
100.00% of 265 companies
in the Diagnostics & Research industry.
Industry Max: 17.42, Med: -0.98, Min: -1428.57
GH: -1.45
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -3.3, Med: -1.8, Max: -1.1
Current: -1.45
-3.3
-1.1

More Statistics

Revenue (TTM) (Mil) $ 110.6
EPS (TTM) $ -1.39
Beta 0
Volatility % 0
52-Week Range $ 27.04 - 106.58
Shares Outstanding (Mil) 85.83

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 0
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N